Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Tumor Angiocrine Signaling : Novel Targeting Opportunity in Cancer. / Oria, Victor Oginga; Erler, Janine Terra.

I: Cells, Bind 12, Nr. 20, 2510, 2023.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Oria, VO & Erler, JT 2023, 'Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer', Cells, bind 12, nr. 20, 2510. https://doi.org/10.3390/cells12202510

APA

Oria, V. O., & Erler, J. T. (2023). Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer. Cells, 12(20), [2510]. https://doi.org/10.3390/cells12202510

Vancouver

Oria VO, Erler JT. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer. Cells. 2023;12(20). 2510. https://doi.org/10.3390/cells12202510

Author

Oria, Victor Oginga ; Erler, Janine Terra. / Tumor Angiocrine Signaling : Novel Targeting Opportunity in Cancer. I: Cells. 2023 ; Bind 12, Nr. 20.

Bibtex

@article{bbff0c1544e648558e33fbf259fc65ba,
title = "Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer",
abstract = "The vascular endothelium supplies nutrients and oxygen to different body organs and supports the progression of diseases such as cancer through angiogenesis. Pathological angiogenesis remains a challenge as most patients develop resistance to the approved anti-angiogenic therapies. Therefore, a better understanding of endothelium signaling will support the development of more effective treatments. Over the past two decades, the emerging consensus suggests that the role of endothelial cells in tumor development has gone beyond angiogenesis. Instead, endothelial cells are now considered active participants in the tumor microenvironment, secreting angiocrine factors such as cytokines, growth factors, and chemokines, which instruct their proximate microenvironments. The function of angiocrine signaling is being uncovered in different fields, such as tissue homeostasis, early development, organogenesis, organ regeneration post-injury, and tumorigenesis. In this review, we elucidate the intricate role of angiocrine signaling in cancer progression, including distant metastasis, tumor dormancy, pre-metastatic niche formation, immune evasion, and therapy resistance.",
keywords = "angiocrine factors, angiocrine signaling, endothelium",
author = "Oria, {Victor Oginga} and Erler, {Janine Terra}",
note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2023",
doi = "10.3390/cells12202510",
language = "English",
volume = "12",
journal = "Cells",
issn = "2073-4409",
publisher = "MDPI AG",
number = "20",

}

RIS

TY - JOUR

T1 - Tumor Angiocrine Signaling

T2 - Novel Targeting Opportunity in Cancer

AU - Oria, Victor Oginga

AU - Erler, Janine Terra

N1 - Publisher Copyright: © 2023 by the authors.

PY - 2023

Y1 - 2023

N2 - The vascular endothelium supplies nutrients and oxygen to different body organs and supports the progression of diseases such as cancer through angiogenesis. Pathological angiogenesis remains a challenge as most patients develop resistance to the approved anti-angiogenic therapies. Therefore, a better understanding of endothelium signaling will support the development of more effective treatments. Over the past two decades, the emerging consensus suggests that the role of endothelial cells in tumor development has gone beyond angiogenesis. Instead, endothelial cells are now considered active participants in the tumor microenvironment, secreting angiocrine factors such as cytokines, growth factors, and chemokines, which instruct their proximate microenvironments. The function of angiocrine signaling is being uncovered in different fields, such as tissue homeostasis, early development, organogenesis, organ regeneration post-injury, and tumorigenesis. In this review, we elucidate the intricate role of angiocrine signaling in cancer progression, including distant metastasis, tumor dormancy, pre-metastatic niche formation, immune evasion, and therapy resistance.

AB - The vascular endothelium supplies nutrients and oxygen to different body organs and supports the progression of diseases such as cancer through angiogenesis. Pathological angiogenesis remains a challenge as most patients develop resistance to the approved anti-angiogenic therapies. Therefore, a better understanding of endothelium signaling will support the development of more effective treatments. Over the past two decades, the emerging consensus suggests that the role of endothelial cells in tumor development has gone beyond angiogenesis. Instead, endothelial cells are now considered active participants in the tumor microenvironment, secreting angiocrine factors such as cytokines, growth factors, and chemokines, which instruct their proximate microenvironments. The function of angiocrine signaling is being uncovered in different fields, such as tissue homeostasis, early development, organogenesis, organ regeneration post-injury, and tumorigenesis. In this review, we elucidate the intricate role of angiocrine signaling in cancer progression, including distant metastasis, tumor dormancy, pre-metastatic niche formation, immune evasion, and therapy resistance.

KW - angiocrine factors

KW - angiocrine signaling

KW - endothelium

U2 - 10.3390/cells12202510

DO - 10.3390/cells12202510

M3 - Review

C2 - 37887354

AN - SCOPUS:85175003021

VL - 12

JO - Cells

JF - Cells

SN - 2073-4409

IS - 20

M1 - 2510

ER -

ID: 372967420